PRDM1 and neoplasm: To further assess the importance of the role of BVax Igs, we conducted experiments in which we treated CT2A tumor–bearing mice with BVax generated from WT mice or mice with B cells deficient in Prdm1 (Cd19Cre Prdm1fl mice, provided by Nicole Baumgarth, Johns Hopkins Medicine, Baltimore, Maryland, USA).